A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Summary

Although Cystic Fibrosis is a complex genetic disease affecting many organs, lung disease is the primary cause of mortality. The objective of this study is to determine the safety and tolerability of SNSP113 in healthy subjects and subjects with stable cystic fibrosis.

Timeline

Start

2017-09-28

Primary completion

2017-12-18

Completion

2017-12-18

Outcome

Outcome not reported

Stopped: “Successful completion of Part A. Company decision to end early.”

Drugs

Indications